Archive: Raymond J. March

Raymond J. March is a Research Fellow at the Independent Institute.
Full Biography and Publications
The Mental Health Crisis and FDA Hurdles
Despite promising research, the potential for MDMA, and other psychedelic drugs to help treat mental illnesses depends on the a pending FDA decision
Raymond J. March | September 15, 2023
Favor Local Action to Combat the Coronavirus
The government’s tendency to take drastic action and achieve lackluster results suggest that local efforts to mitigate crises might be more successful.
Raymond J. March | March 21, 2020
Are More Vaping Bans Coming Soon? Let’s Hope Not!
To truly “prioritize children, family, and the public health,” we should consider telling the FDA to stop regulating e-cigarettes cold turkey.
Raymond J. March | January 25, 2020
Only Markets Can Alleviate Drug Shortages
The most onerous barriers to alleviating drug shortages are regulations.
Raymond J. March | December 20, 2019
New FDA Commissioner, Same FDA Problem
The most beneficial regulations the new FDA commissioner can implement, by far, will be restrictions on the FDA itself.
Raymond J. March | December 10, 2019
Telemedicine Continues to Reach New Heights
Thankfully, telemedicine provides solutions for many who might otherwise suffer healthcare-access woes.
Raymond J. March | November 29, 2019
Breakthrough Alzheimer’s Drug Puts FDA’s Drug-Approval Process into Question
Peer-reviewed research and many case studies highlight weaknesses in the FDAs drug approval approach.
Raymond J. March | November 11, 2019
Is Right-to-Try Legislation a Bust? Time for a Second Opinion.
While right-to-try is currently underused, efforts to expand its role in helping those with terminal illnesses are underway.
Raymond J. March | October 26, 2019
Banning E-Cigarette Sales Will Do More Harm than Good
Efforts to ban vaping are extremely unlikely to succeed and may push consumers toward harmful alternatives.
Raymond J. March | September 13, 2019
How Government Prolonged the Lobotomy
While the lobotomy offers a cautionary tale of medicine gone astray, it should also provide a cautionary tale of the harmful consequences of state-assisted health policies.
Raymond J. March | August 31, 2019
New Study Finds FDA in Contempt of the U.S. Constitution
The vast majority of agency regulations were passed by “low-level officials and employees with no authority to issue rules.”
Raymond J. March | August 28, 2019
Worried About Big Pharma? Then Reduce the FDA’s Regulatory Power.
To compete for FDA attention, drug makers now needed a way to navigate new safety hurdles to have their products approved.
Raymond J. March | August 9, 2019